Style | Citing Format |
---|---|
MLA | Abdullkareem FA, et al.. "Relationship Between Gallstone and Biliary Tract Neoplasm; a Systematic Review and Meta-Analysis of Cohort and Case-Control Studies." Immunopathologia Persa, vol. 11, no. 2, 2025, pp. -. |
APA | Abdullkareem FA, Jorshari ST, Kadhum AA, Emamieh S, Golnavaz M, Zandiyeh F, Zaremoghadam E, Mirshekari A, Ghaffariyan S (2025). Relationship Between Gallstone and Biliary Tract Neoplasm; a Systematic Review and Meta-Analysis of Cohort and Case-Control Studies. Immunopathologia Persa, 11(2), -. |
Chicago | Abdullkareem FA, Jorshari ST, Kadhum AA, Emamieh S, Golnavaz M, Zandiyeh F, Zaremoghadam E, Mirshekari A, Ghaffariyan S. "Relationship Between Gallstone and Biliary Tract Neoplasm; a Systematic Review and Meta-Analysis of Cohort and Case-Control Studies." Immunopathologia Persa 11, no. 2 (2025): -. |
Harvard | Abdullkareem FA et al. (2025) 'Relationship Between Gallstone and Biliary Tract Neoplasm; a Systematic Review and Meta-Analysis of Cohort and Case-Control Studies', Immunopathologia Persa, 11(2), pp. -. |
Vancouver | Abdullkareem FA, Jorshari ST, Kadhum AA, Emamieh S, Golnavaz M, Zandiyeh F, et al.. Relationship Between Gallstone and Biliary Tract Neoplasm; a Systematic Review and Meta-Analysis of Cohort and Case-Control Studies. Immunopathologia Persa. 2025;11(2):-. |
BibTex | @article{ author = {Abdullkareem FA and Jorshari ST and Kadhum AA and Emamieh S and Golnavaz M and Zandiyeh F and Zaremoghadam E and Mirshekari A and Ghaffariyan S}, title = {Relationship Between Gallstone and Biliary Tract Neoplasm; a Systematic Review and Meta-Analysis of Cohort and Case-Control Studies}, journal = {Immunopathologia Persa}, volume = {11}, number = {2}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Abdullkareem FA AU - Jorshari ST AU - Kadhum AA AU - Emamieh S AU - Golnavaz M AU - Zandiyeh F AU - Zaremoghadam E AU - Mirshekari A AU - Ghaffariyan S TI - Relationship Between Gallstone and Biliary Tract Neoplasm; a Systematic Review and Meta-Analysis of Cohort and Case-Control Studies JO - Immunopathologia Persa VL - 11 IS - 2 SP - EP - PY - 2025 ER - |